PL2925128T3 - Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca - Google Patents
Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności sercaInfo
- Publication number
- PL2925128T3 PL2925128T3 PL13848937T PL13848937T PL2925128T3 PL 2925128 T3 PL2925128 T3 PL 2925128T3 PL 13848937 T PL13848937 T PL 13848937T PL 13848937 T PL13848937 T PL 13848937T PL 2925128 T3 PL2925128 T3 PL 2925128T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- blood pressure
- heart failure
- controlling blood
- reducing dyspnea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dermatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261719127P | 2012-10-26 | 2012-10-26 | |
| PCT/US2013/066990 WO2014066870A1 (en) | 2012-10-26 | 2013-10-26 | Methods for controlling blood pressure and reducing dyspnea in heart failure |
| EP13848937.2A EP2925128B1 (en) | 2012-10-26 | 2013-10-26 | Methods for controlling blood pressure and reducing dyspnea in heart failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2925128T3 true PL2925128T3 (pl) | 2018-10-31 |
Family
ID=50545374
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13848937T PL2925128T3 (pl) | 2012-10-26 | 2013-10-26 | Sposoby kontrolowania ciśnienia krwi i zmniejszania duszności w niewydolności serca |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10881645B2 (pl) |
| EP (1) | EP2925128B1 (pl) |
| JP (2) | JP6329957B2 (pl) |
| KR (1) | KR102299073B1 (pl) |
| CN (2) | CN110840890A (pl) |
| AU (1) | AU2013334081B2 (pl) |
| BR (1) | BR112015009291B1 (pl) |
| CA (1) | CA2889584C (pl) |
| EA (1) | EA030354B1 (pl) |
| ES (1) | ES2671639T3 (pl) |
| IL (1) | IL238462A0 (pl) |
| MX (1) | MX359768B (pl) |
| NZ (1) | NZ708511A (pl) |
| PL (1) | PL2925128T3 (pl) |
| TR (1) | TR201807636T4 (pl) |
| UA (1) | UA117571C2 (pl) |
| WO (1) | WO2014066870A1 (pl) |
| ZA (1) | ZA201503741B (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11737989B2 (en) | 2014-05-19 | 2023-08-29 | Chiesi Farmaceutici S.P.A. | Clevidipine nanoparticles and pharmaceutical compositions thereof |
| JP2022523821A (ja) * | 2019-03-05 | 2022-04-26 | ウインドトゥリー・セラピューティクス・インコーポレイテッド | 急性心不全（ａｈｆ）の治療のためのイスタロキシム含有静脈用製剤 |
| CN114966056B (zh) * | 2022-06-08 | 2024-07-02 | 四川大学华西医院 | 筛查急性主动脉夹层的试剂盒和系统 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9303657D0 (sv) | 1993-11-05 | 1993-11-05 | Astra Ab | Short-acting dihydropyridines |
| SE9303744D0 (sv) | 1993-11-12 | 1993-11-12 | Astra Ab | Pharmaceutical emulsion |
| SE9804002D0 (sv) | 1998-11-23 | 1998-11-23 | Astra Ab | New manufacturing process |
| GB2462221B (en) * | 2008-05-16 | 2010-09-01 | Corthera Inc | Administration of relaxin to reduce diuretic use in humans with acute decompensated heart failure |
| KR20160095206A (ko) | 2008-08-01 | 2016-08-10 | 더 메디슨스 컴퍼니 | 약제학적 조성물 및 이를 안정화시키는 방법 |
| JP5674660B2 (ja) | 2008-08-01 | 2015-02-25 | ザ メディシンズ カンパニー | 医薬組成物および不純物の濃度が低い医薬組成物の製造方法 |
| BR112012011298B1 (pt) | 2009-11-11 | 2021-12-14 | Chiesi Farmaceutici S.P.A. | Uso de cangrelor e/ou bivalirudina na preparação de medicamentos e combinação de medicamentos |
| TW201215392A (en) | 2010-06-16 | 2012-04-16 | Gilead Sciences Inc | Use of ranolazine for treating pulmonary hypertension |
| WO2012051116A1 (en) * | 2010-10-12 | 2012-04-19 | The Medicines Company | Clevidipine emulsion formulations containing antimicrobial agents |
| JP2014509654A (ja) * | 2011-04-01 | 2014-04-21 | ザ メディシンズ カンパニー | 脳卒中損傷の低減に使用するための短時間作用型ジヒドロピリジン（クレビジピン） |
-
2013
- 2013-10-26 BR BR112015009291-8A patent/BR112015009291B1/pt active IP Right Grant
- 2013-10-26 KR KR1020157013890A patent/KR102299073B1/ko active IP Right Grant
- 2013-10-26 WO PCT/US2013/066990 patent/WO2014066870A1/en active Application Filing
- 2013-10-26 EA EA201590825A patent/EA030354B1/ru unknown
- 2013-10-26 PL PL13848937T patent/PL2925128T3/pl unknown
- 2013-10-26 US US14/064,137 patent/US10881645B2/en active Active
- 2013-10-26 EP EP13848937.2A patent/EP2925128B1/en active Active
- 2013-10-26 NZ NZ708511A patent/NZ708511A/en unknown
- 2013-10-26 AU AU2013334081A patent/AU2013334081B2/en active Active
- 2013-10-26 TR TR2018/07636T patent/TR201807636T4/tr unknown
- 2013-10-26 JP JP2015539879A patent/JP6329957B2/ja active Active
- 2013-10-26 CA CA2889584A patent/CA2889584C/en active Active
- 2013-10-26 ES ES13848937.2T patent/ES2671639T3/es active Active
- 2013-10-26 MX MX2015005341A patent/MX359768B/es active IP Right Grant
- 2013-10-26 UA UAA201505170A patent/UA117571C2/uk unknown
- 2013-10-26 CN CN201911070111.9A patent/CN110840890A/zh active Pending
- 2013-10-26 CN CN201380068074.2A patent/CN104968199A/zh active Pending
-
2015
- 2015-04-26 IL IL238462A patent/IL238462A0/en active IP Right Grant
- 2015-05-26 ZA ZA2015/03741A patent/ZA201503741B/en unknown
-
2018
- 2018-01-31 JP JP2018014665A patent/JP2018065875A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EA030354B1 (ru) | 2018-07-31 |
| EP2925128B1 (en) | 2018-04-11 |
| US10881645B2 (en) | 2021-01-05 |
| BR112015009291B1 (pt) | 2021-03-16 |
| UA117571C2 (uk) | 2018-08-27 |
| AU2013334081A1 (en) | 2015-06-11 |
| EP2925128A4 (en) | 2016-06-08 |
| CA2889584C (en) | 2018-08-14 |
| JP2018065875A (ja) | 2018-04-26 |
| BR112015009291A2 (pt) | 2017-07-04 |
| CN104968199A (zh) | 2015-10-07 |
| KR102299073B1 (ko) | 2021-09-09 |
| EA201590825A1 (ru) | 2015-09-30 |
| ES2671639T3 (es) | 2018-06-07 |
| CA2889584A1 (en) | 2014-05-01 |
| AU2013334081B2 (en) | 2017-05-18 |
| IL238462A0 (en) | 2015-06-30 |
| MX2015005341A (es) | 2016-05-24 |
| NZ708511A (en) | 2018-11-30 |
| EP2925128A1 (en) | 2015-10-07 |
| ZA201503741B (en) | 2022-09-28 |
| MX359768B (es) | 2018-10-10 |
| JP6329957B2 (ja) | 2018-05-23 |
| JP2015535258A (ja) | 2015-12-10 |
| TR201807636T4 (tr) | 2018-06-21 |
| WO2014066870A1 (en) | 2014-05-01 |
| CN110840890A (zh) | 2020-02-28 |
| KR20150104084A (ko) | 2015-09-14 |
| US20140121247A1 (en) | 2014-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1226016B (zh) | 用於通過控制心房壓力來控制血壓的方法和系統 | |
| EP2916725A4 (en) | IMPROVED MONITORING DEVICE AND METHOD FOR BLOOD PRESSURE | |
| IL232086B (en) | Syringe and method for pressure regulation | |
| EP2849681A4 (en) | DEVICES AND METHODS FOR REDUCING CARDIAC VALVULAR REGURGITATION | |
| EP2793985A4 (en) | SYSTEMS AND METHOD FOR THERAPEUTIC INTRATHORACOAL PRESSURE REGULATION | |
| IL238933A0 (en) | Device and method for treating malfunction of a heart valve | |
| IL233921A0 (en) | Reversible tissue valve and method | |
| EP2892489A4 (en) | INFLATABLE MATTRESS AND CONTROL METHODS | |
| HK1207012A1 (en) | System for monitoring and controlling organ blood perfusion | |
| HK1210729A1 (en) | Medical pump and method of operating the same | |
| EP2906151A4 (en) | HEART TREATMENT SYSTEM AND METHOD | |
| SG11201500606UA (en) | Patient interface and method for making same | |
| EP2788075A4 (en) | DEVICE AND METHOD FOR REDUCING THE TRANSTHORACOID IMPEDANCE OF A PATIENT | |
| EP2811897A4 (en) | MEDICAL TERMINAL AND APPLICATION METHOD | |
| SG11201601294PA (en) | Method for producing retinal tissue and retina-related cells | |
| EP2566386A4 (en) | DEVICES AND METHODS FOR CONTROLLING BLOOD PRESSURE | |
| IL239030A0 (en) | Devices and methods for replacing the function of heart valves | |
| SG11201405682VA (en) | Valve and hydraulic controller | |
| HK1208617A1 (en) | Compression and decompression control system and vascular strengthening method | |
| SG11201405681XA (en) | Valve and hydraulic controller | |
| EP2891465A4 (en) | MEDICAL SYSTEM AND METHOD OF OPERATION | |
| HK1213324A1 (zh) | 心力衰竭療法的選擇中的生物標記物 | |
| HK1213799A1 (zh) | 降低與心臟衰竭相關的風險和與其相關的因素的方法 | |
| IL239045A0 (en) | Tissue binding implant device and method | |
| EP2903632A4 (en) | COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE IN DIABETES PATIENTS |